KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Net Income (2016 - 2025)

Historic Net Income for Pfizer (PFE) over the last 17 years, with Q2 2025 value amounting to $25.0 million.

  • Pfizer's Net Income rose 4705.88% to $25.0 million in Q2 2025 from the same period last year, while for Sep 2025 it was $25.0 million, marking a year-over-year increase of 21363.64%. This contributed to the annual value of $11.0 million for FY2024, which is 17333.33% up from last year.
  • Pfizer's Net Income amounted to $25.0 million in Q2 2025, which was up 4705.88% from -$8.0 million recorded in Q3 2024.
  • Pfizer's 5-year Net Income high stood at $34.0 million for Q3 2022, and its period low was -$236.0 million during Q3 2021.
  • In the last 5 years, Pfizer's Net Income had a median value of -$3.5 million in 2023 and averaged -$16.4 million.
  • In the last 5 years, Pfizer's Net Income crashed by 100000.0% in 2022 and then skyrocketed by 95000.0% in 2024.
  • Quarter analysis of 5 years shows Pfizer's Net Income stood at -$13.0 million in 2021, then crashed by 61.54% to -$21.0 million in 2022, then decreased by 23.81% to -$26.0 million in 2023, then skyrocketed by 69.23% to -$8.0 million in 2024, then skyrocketed by 412.5% to $25.0 million in 2025.
  • Its Net Income stands at $25.0 million for Q2 2025, versus -$8.0 million for Q3 2024 and $17.0 million for Q2 2024.